Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Knee scooter therapy aims to help children with one-sided weakness walk better

NCT ID NCT07686809

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests a modified leg therapy for children ages 6 to 8 with hemiplegic cerebral palsy, a condition that affects one side of the body. The therapy uses a knee scooter to encourage use of the weaker leg during walking tasks. Researchers will measure changes in walking patterns and mobility compared to standard physical therapy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
modified constraint-induced movement therapy using a knee scooter
What this could lead to
If it works, this therapy could offer a simple, low-cost way to improve walking and mobility in children with hemiplegia.
What could go wrong
This is a small, early-stage trial with only 30 children, so results may not apply to all. The therapy may not lead to lasting improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 8 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. The age of the selected children will range from 6 to 8 years old. 2. Degree of spasticity will range from 1+ to 2 according to the modified Ashworth scale. 3. The level of motor function of the children will be levels I-II according to the Gross Motor Function Classification System. 4. Participants will present a score between 41 to 56 points on the pediatric balance scale. 5. They will be able to follow instructions and understand commands. Exclusion Criteria: 1. Bone and tendon lengthening surgeries within the last 6 months. 2. Lung and heart diseases and disorders. 3. Vision or hearing problems. 4. Children with fixed deformities in the lower extremity. 5. Children with epilepsy. 6. Recent intramuscular Botulinum toxin injection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spastic hemiplegic cerebral palsy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • outpatient clinic faculty of physical therapy, Cairo University

    RECRUITING

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.